Related Experiment Videos
[Meta-analysis of clinical trials: how to separate the good grain from the chaff]
1Service de biostatistique et d'épidémiologie, Institut Gustave-Roussy, Villejuif.
Bulletin Du Cancer
|October 3, 1999
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Circulating innate immune markers and outcomes in treatment-naïve advanced non-small cell lung cancer patients.
European journal of cancer (Oxford, England : 1990)·2019
[New developments in the management of nasopharyngeal carcinoma].
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2018
Pazopanib or placebo in completely resected stage I NSCLC patients: results of the phase II IFCT-0703 trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2017
Does KRAS mutational status predict chemoresistance in advanced non-small cell lung cancer (NSCLC)?
Lung cancer (Amsterdam, Netherlands)·2014
[Evolving strategies for relapsed multiple myeloma: Toward personalized treatment in 2026].
Bulletin du cancer·2026
[Informational stress among oncologists: an exploratory survey].
Bulletin du cancer·2026
[Follow-up of the long-term survivors of transplantation and cellular therapy - SFGM-TC].
Bulletin du cancer·2026